Vikas Mehta | Dec 27, 2024, 6:55 PM IST
Among the regional parties, the TDP received over Rs 100 crore in donations for 2023-24, while the Samajwadi Party received Rs 46.7 lakh in contributions, down from Rs 33 crore the previous year. In 2023-24, the YSR Congress, the DMK, and the JMM received donations of Rs 121.5 crore, Rs 60 crore, and Rs 11.5 crore, respectively.
Manmath Nayak | Dec 27, 2022, 3:29 PM IST
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose.
India.com News Desk | Dec 27, 2022, 12:07 PM IST
The intra-nasal vaccine would be available at private vaccination centres by the end of January.
Tahir Qureshi | Dec 24, 2022, 3:58 PM IST
To fight the Coronavirus, the government has included Bharat Biotech's nasal vaccine in the vaccination program as a booster dose.
Victor Dasgupta | Dec 22, 2022, 5:18 PM IST
CM Yogi instructed them to conduct genome sequencing of every positive case and increase pace of COVID testing, precaution dose.
Victor Dasgupta | Nov 28, 2022, 6:50 PM IST
Bharat Biotech International Limited (BBIL) announced that iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO)
India.com Business Desk | Nov 4, 2022, 9:17 AM IST
More than 200 million doses of the Indian made Covaxin in its bulk form and 50 million doses in vials will expire in early 2023, said a report. It added that the company had stopped production earlier this year.
India.com News Desk | Sep 6, 2022, 3:14 PM IST
The nasal Covid vaccine had last month completed the phase-III and booster dose trials and Bharat Biotech said it had conducted two separate trials for its intranasal Covid vaccine, one as a primary dose schedule and another as a booster dose.
India.com News Desk | Aug 15, 2022, 3:36 PM IST
According to the company, BBV154 is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
India.com News Desk | Jul 17, 2022, 7:47 AM IST
Covaxin, an inactivated whole-virion vaccine to fight COVID developed by Bharat Biotech, may help reduce the severity, according to a study.
India.com News Desk | Jul 8, 2022, 6:33 PM IST
The Standing Technical Sub-Committee of the NTAGI said Biological E's Corbevax has been recommended for administration in 5 to 12 years old children, while Bharat Biotech's Covaxin for children in the 6-12 years age group.
India.com News Desk | May 26, 2022, 5:26 PM IST
International Travel Latest Update: Apart from Germany, several countries including Australia, Japan and Canada are now allowing Indian passengers vaccinated with Covaxin into their countries.
English
